Replacement: Scrip Dividend Scheme

RNS Number : 2852I

The MedicX Fund Limited

26 August 2016

 

For immediate release

26 August 2016

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Correction - Mandate Delivery Deadline for the September 2016 Dividend in relation to the Scrip Dividend Scheme

Further to the announcement made by MedicX Fund Limited on 25 August 2016 the Board hereby advises that the Mandate Delivery Deadline is actually 5.00 p.m. on 9 September 2016, not 9 August as previously stated.

The corrected paragraph should read as follows -

"In order to be valid, Mandate forms must be received by the Company's registrars, Capita Asset Services, (or CREST instructions entered) by no later than 5.00 p.m. on 9 September 2016 (the "Mandate Delivery Deadline") in order for elections under the Scrip Dividend Scheme to be effective in relation to the September 2016 Dividend. The Company mailed, on 23 August 2016, personalised Mandate Forms to Shareholders new on the Register since 20 May 2016 and before 19 August 2016 (the "Record Date"). Other Shareholders can use their Mandate Forms issued for previous scrip dividends offered, or obtain Mandate Forms from Capita Asset Services".

The Board of the Company apologise for any confusion or concern which the incorrect announcement may have caused.

End

For further information please contact:

MedicX Fund                                                                  [phone]

David Staples, Chairman

Octopus Healthcare Group                                               [phone]

Mike Adams, Chief Executive Officer

Buchanan                                                                      [phone]

Charles Ryland/Vicky Hayns

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 152 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1 billion of healthcare investments across a number of platforms, with a focus on four core areas: GP surgeries, care homes, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £5.5 billion of funds for more than 50,000 retail and institutional investors.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

MSCSEFFDMFMSELA